These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 12086720)

  • 21. Temperature-responsive, Pluronic-g-poly(acrylic acid) copolymers in situ gels for ophthalmic drug delivery: rheology, in vitro drug release, and in vivo resident property.
    Ma WD; Xu H; Nie SF; Pan WS
    Drug Dev Ind Pharm; 2008 Mar; 34(3):258-66. PubMed ID: 18363141
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pluronic F127-g-poly(acrylic acid) copolymers as in situ gelling vehicle for ophthalmic drug delivery system.
    Ma WD; Xu H; Wang C; Nie SF; Pan WS
    Int J Pharm; 2008 Feb; 350(1-2):247-56. PubMed ID: 17961940
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Xyloglucan as a novel vehicle for timolol: pharmacokinetics and pressure lowering activity in rabbits.
    Burgalassi S; Chetoni P; Panichi L; Boldrini E; Saettone MF
    J Ocul Pharmacol Ther; 2000 Dec; 16(6):497-509. PubMed ID: 11132897
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In situ gelling systems based on Pluronic F127/Pluronic F68 formulations for ocular drug delivery.
    Al Khateb K; Ozhmukhametova EK; Mussin MN; Seilkhanov SK; Rakhypbekov TK; Lau WM; Khutoryanskiy VV
    Int J Pharm; 2016 Apr; 502(1-2):70-9. PubMed ID: 26899977
    [TBL] [Abstract][Full Text] [Related]  

  • 25. How can the bioavailability of timolol be enhanced? A pharmacokinetic pilot study of novel hydrogels.
    von der Ohe N; Stark M; Mayer H; Brewitt H
    Graefes Arch Clin Exp Ophthalmol; 1996 Jul; 234(7):452-6. PubMed ID: 8817289
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of O/W nanoemulsions for ophthalmic administration of timolol.
    Gallarate M; Chirio D; Bussano R; Peira E; Battaglia L; Baratta F; Trotta M
    Int J Pharm; 2013 Jan; 440(2):126-34. PubMed ID: 23078859
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Poly(N-isopropylacrylamide)-chitosan as thermosensitive in situ gel-forming system for ocular drug delivery.
    Cao Y; Zhang C; Shen W; Cheng Z; Yu LL; Ping Q
    J Control Release; 2007 Jul; 120(3):186-94. PubMed ID: 17582643
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma timolol concentrations of timolol maleate: timolol gel-forming solution (TIMOPTIC-XE) once daily versus timolol maleate ophthalmic solution twice daily.
    Shedden AH; Laurence J; Barrish A; Olah TV
    Doc Ophthalmol; 2001 Jul; 103(1):73-9. PubMed ID: 11678162
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ophthalmic administration of a 10-fold-lower dose of conventional nanoliposome formulations caused levels of intraocular pressure similar to those induced by marketed eye drops.
    Arroyo CM; Quinteros D; Cózar-Bernal MJ; Palma SD; Rabasco AM; González-Rodríguez ML
    Eur J Pharm Sci; 2018 Jan; 111():186-194. PubMed ID: 28923571
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Timolol transport from microemulsions trapped in HEMA gels.
    Li CC; Abrahamson M; Kapoor Y; Chauhan A
    J Colloid Interface Sci; 2007 Nov; 315(1):297-306. PubMed ID: 17673246
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transdermal iontophoretic delivery of timolol maleate in albino rabbits.
    Kanikkannan N; Singh J; Ramarao P
    Int J Pharm; 2000 Mar; 197(1-2):69-76. PubMed ID: 10704794
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liposome incorporated ion sensitive in situ gels for opthalmic delivery of timolol maleate.
    Yu S; Wang QM; Wang X; Liu D; Zhang W; Ye T; Yang X; Pan W
    Int J Pharm; 2015 Mar; 480(1-2):128-36. PubMed ID: 25615987
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In situ gelling xyloglucan formulations for sustained release ocular delivery of pilocarpine hydrochloride.
    Miyazaki S; Suzuki S; Kawasaki N; Endo K; Takahashi A; Attwood D
    Int J Pharm; 2001 Oct; 229(1-2):29-36. PubMed ID: 11604255
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pluronic F127-based ocular delivery system containing biodegradable polyisobutylcyanoacrylate nanocapsules of pilocarpine.
    Desai SD; Blanchard J
    Drug Deliv; 2000; 7(4):201-7. PubMed ID: 11195426
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Physicochemical properties and in vivo assessment of timolol-loaded poly(D,L-lactide-co-glycolide) films for long-term intraocular pressure lowering effects.
    Huang SF; Chen JL; Yeh MK; Chiang CH
    J Ocul Pharmacol Ther; 2005 Dec; 21(6):445-53. PubMed ID: 16386086
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Promoting effect of borneol on the permeability of puerarin eye drops and timolol maleate eye drops through the cornea in vitro.
    Wu CJ; Huang QW; Qi HY; Guo P; Hou SX
    Pharmazie; 2006 Sep; 61(9):783-8. PubMed ID: 17020156
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modification of in situ gelling behavior of carbopol solutions by hydroxypropyl methylcellulose.
    Kumar S; Himmelstein KJ
    J Pharm Sci; 1995 Mar; 84(3):344-8. PubMed ID: 7616375
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimization and evaluation of thermoresponsive diclofenac sodium ophthalmic in situ gels.
    Asasutjarit R; Thanasanchokpibull S; Fuongfuchat A; Veeranondha S
    Int J Pharm; 2011 Jun; 411(1-2):128-35. PubMed ID: 21459137
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Controlled delivery of recombinant hirudin based on thermo-sensitive Pluronic F127 hydrogel for subcutaneous administration: In vitro and in vivo characterization.
    Liu Y; Lu WL; Wang JC; Zhang X; Zhang H; Wang XQ; Zhou TY; Zhang Q
    J Control Release; 2007 Feb; 117(3):387-95. PubMed ID: 17207884
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ion- and pH-activated novel in-situ gel system for sustained ocular drug delivery.
    Gupta H; Velpandian T; Jain S
    J Drug Target; 2010 Aug; 18(7):499-505. PubMed ID: 20055752
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.